Stephen J Schuster Selected Research

Failure to Thrive

4/2021

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Schuster Research Topics

Disease

47	Neoplasms (Cancer) 04/2024 - 11/2002
35	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 03/2004
32	Lymphoma (Lymphomas) 03/2024 - 06/2003
28	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 08/2004
25	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 06/2008
24	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 11/2008
20	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 06/2003
14	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 09/2006
11	Disease Progression 12/2023 - 09/2008
7	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2019 - 11/2002
6	Cytokine Release Syndrome 12/2023 - 12/2018
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 09/2011
5	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 04/2010
5	Neutropenia 01/2022 - 01/2003
5	Pneumonia (Pneumonitis) 04/2021 - 11/2010
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 01/2003
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 06/2004
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 09/2003
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 03/2014
4	Diarrhea 01/2021 - 03/2014
3	Infections 04/2021 - 01/2003
3	Atrial Fibrillation 04/2021 - 12/2018
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2020 - 01/2016
3	Hemorrhage 01/2020 - 01/2017
3	Tumor Lysis Syndrome 01/2019 - 01/2018
3	Fatigue 12/2018 - 07/2014
3	Cough 11/2018 - 07/2014
3	Multiple Myeloma 10/2016 - 11/2010
2	COVID-19 11/2023 - 01/2020
2	Febrile Neutropenia 04/2021 - 04/2010
2	Pathologic Complete Response 01/2019 - 12/2017
2	Fever (Fevers) 11/2018 - 07/2014
2	Nausea 11/2017 - 07/2014
2	Lymphocytosis 07/2014 - 09/2003
1	Leukemia 04/2024
1	Cytopenia 03/2024
1	Skin Neoplasms (Skin Cancer) 11/2023

Drug/Important Bio-Agent (IBA)

38	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2016
26	tisagenlecleucelIBA 01/2024 - 01/2016
25	Rituximab (Mabthera)FDA Link 01/2024 - 06/2003
15	ibrutinibIBA 11/2022 - 07/2014
10	Lenalidomide (CC 5013)FDA Link 11/2023 - 11/2010
10	venetoclaxIBA 01/2023 - 01/2018
8	axicabtagene ciloleucelIBA 01/2024 - 12/2019
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 09/2003
6	AntigensIBA 12/2023 - 07/2011
6	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 10/2018
6	Bexarotene (LGD1069)FDA Link 01/2021 - 08/2005
5	fludarabineIBA 12/2023 - 02/2009
5	Monoclonal AntibodiesIBA 06/2021 - 06/2003
5	Phosphotransferases (Kinase)IBA 01/2021 - 09/2006
4	Bendamustine Hydrochloride FDA Link 04/2024 - 11/2020
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2013
4	RNA (Ribonucleic Acid)IBA 11/2023 - 08/2007
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2003
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 09/2003
3	Bispecific AntibodiesIBA 03/2024 - 06/2021
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 10/2020
3	Alkylating AgentsIBA 01/2022 - 03/2014
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2003
3	idelalisibIBA 01/2021 - 03/2014
3	CytokinesIBA 01/2019 - 09/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 01/2003
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014 - 09/2003
3	epratuzumabIBA 11/2008 - 12/2003
2	VaccinesIBA 04/2024 - 03/2024
2	pembrolizumabIBA 01/2023 - 01/2022
2	Brentuximab VedotinIBA 01/2021 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2011
2	tocilizumab (atlizumab)FDA Link 11/2020 - 01/2020
2	ofatumumab FDA Link 12/2018 - 07/2014
2	Immunoglobulin G (IgG)IBA 12/2017 - 12/2003
2	Immunoglobulin M (IgM)IBA 12/2017 - 03/2004
2	NivolumabIBA 10/2016 - 01/2015
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 12/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 03/2014 - 08/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2011 - 09/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 04/2010
2	Vincristine (Oncovin)FDA LinkGeneric 01/2011 - 09/2003
2	ORALIT (ORS)IBA 07/2009 - 08/2004
2	RetinoidsIBA 10/2008 - 08/2005
1	brexucabtagene autoleucelIBA 03/2024
1	mRNA VaccinesIBA 03/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024
1	AnthracyclinesIBA 12/2023
1	Everolimus FDA Link 01/2023
1	Vancomycin FDA LinkGeneric 01/2023
1	pomalidomideIBA 01/2023

Therapy/Procedure

72	Therapeutics 03/2024 - 01/2003
16	Drug Therapy (Chemotherapy) 11/2023 - 01/2003
9	Immunotherapy 01/2024 - 09/2008
8	Stem Cell Transplantation 01/2023 - 10/2013
6	Transplantation 01/2023 - 01/2003
5	Radiotherapy 03/2024 - 09/2008
4	Organ Transplantation 06/2013 - 08/2005
4	Radioimmunotherapy 06/2008 - 06/2003
2	Retreatment 01/2022 - 01/2016
2	Cell Transplantation 12/2019 - 09/2003
2	Aftercare (After-Treatment) 09/2005 - 01/2005
1	Intravenous Infusions 01/2023